Morgan Joseph Reiterates a 'Buy' on Isis Pharmaceuticals (ISIS); Could Be Acquired by Potential Partners
Tweet Send to a Friend
Morgan Joseph reiterates a 'Buy' on Isis Pharmaceuticals (Nasdaq: ISIS), price target $18.
Morgan analyst says, "Yesterday, Isis reported detailed ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Morgan analyst says, "Yesterday, Isis reported detailed ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
